FDA Adverse Event Injury Summary report: N

SOLETRA

MDR report key: 3130361 · Received May 24, 2013

Report

Report Number
3007566237-2013-01743
Event Type
Injury
Date Received
May 24, 2013
Date of Event
February 6, 2013
Report Date
May 10, 2013
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

THE ACTUAL EVENT DATES WERE NOT PROVIDED. THIS DATE IS BASED ON THE DATE OF PUBLICATION OF THE ARTICLE. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS. PRODUCT ID NEU_UNKNOWN_LEAD, SERIAL# UNKNOWN, PRODUCT TYPE LEAD. (B)(4).

Description of Event or Problem · 1

ADDITIONAL INFORMATION RECEIVED REPORTED THAT THE PATIENT HAD MILD CONFUSION IN THE DAYS FOLLOWING LEAD IMPLANTATION.

Description of Event or Problem · 1

SHIH, L. C., VANDERHORST, V. G., LOZANO, A. M., HAMANI, C., MORO, E. IMPROVEMENT OF PISA SYNDROME WITH CONTRALATERAL PEDUNCULOPONTINE STIMULATION. MOVEMENT DISORDERS. 2013;28(4):555-556. DOI: 10.1002/MDS.25301. SUMMARY: A (B)(6) WOMAN WITH A HISTORY OF PARKINSON¿S DISEASE WAS REFERRED FOR PPN DBS SURGERY. FALLS, POSTURE AND GAIT WERE OBSERVED. THE PATIENT SHOWED OVERALL IMPROVEMENT IN PISA SYNDROME. REPORTED EVENT: A (B)(6) WOMAN EXPERIENCED MILD POSTOPERATIVE ENCEPHALOPATHY AND WORD-FINDING DIFFICULTY, FROM WHICH SHE RECOVERED WITHIN 2 WEEKS. AT 14 MONTHS OF FOLLOW-UP, DEMONSTRATED PROGRESSIVE IMPROVEMENT OF HER ASYMMETRIC BRADYKINETIC GAIT AND RIGHT AXIAL LEAN. FURTHER INFORMATION HAS BEEN REQUESTED; A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF ADDITIONAL INFORMATION IS RECEIVED. SEE ATTACHED LITERATURE ARTICLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
231185 SOLETRA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION 7426

Patients

Seq Age Sex Outcome Treatment
1 00062 YR Other